Saku App
Saku Terminal • $MRNALive $MRNA AI Target, Catalysts & Support Levels
OPEN
Saku Logo
Saku
Back to Saku Market Terminal
Climate: STORMY
Updated Nov 22, 2026
Saku AI Market Briefing • $MRNA (Moderna, Inc.)

$MRNA (Moderna, Inc.) Support & Resistance Levels, AI Price Target & Institutional Flow.

Today, $MRNA (Moderna, Inc.) trades at $198.85 (-0.24%) with a 20/100 Momentum Pulse (STORMY) and 14D RSI at 42 (PULLBACK ZONE (42)). Unlock the live $MRNA support and resistance levels, 30D Put Wall floor, 20D SMA pivot, Call Wall ceiling, dark pool flow, and locked 1-Month AI Price Target (+14.2% upside corridor) below—or create a free 24/7 AI quant agent to guard $MRNA.

Saku AI Synthesis • Why Is $MRNA Moving?
30D Support$195.00
30D Resistance$269.00
20-Day SMA$225.26
14-Day RSI42

Moderna (MRNA) stock is down today due to investor concerns over potential share dilution following the pricing of an upsized $2.6 billion offering of 0.00% convertible senior notes due 2032, despite recent positive news regarding its personalized mRNA cancer vaccine and FDA approvals for updated COVID-19 vaccines.

LIVE TERMINAL TELEMETRY
$198.85-0.24%
BEARISH PRESSURE
$MRNA 30-DAY PRICE ACTION • STORMYUpdated Nov 22, 2026
$MRNA Momentum Pulse (1–100)20/100
Fundamental Health Score25/100
Assign Ronin to Guard $MRNA 24/7
3x/Day Shift Briefs & 24/7 Stop-Loss Sentinel
+ GUARD
Locked 1-Month AI Target:$227.09 (+14.2%)Unlock Free →
Open Interactive $MRNA Chart & Ask @Saku
Institutional Quantitative & Fundamental Telemetry

$MRNA (Moderna, Inc.) Live Key Levels, RSI & Valuation Matrix

Updated Nov 22, 2026
$MRNA Technical MetricLive Value$MRNA Fundamental / Regime MetricLive Status
Live Spot Price (24h Change)$198.85 (-0.24%)Market Capitalization$77.85B
30-Day Mechanical Support Floor (Put Wall)$195.00 (1.94% cushion)52-Week High / Low Range$23.55 – $280.80
20-Day Simple Moving Average (20D SMA)$225.26Trailing P/E Ratio & Dividend YieldGrowth / N/A
10-Day Exponential Moving Average (10D EMA)$219.16Average Daily Volume (Liquidity)12.14M shares
30-Day Resistance Ceiling (Call Wall)$269.00 (35.28% upside to test)Next Scheduled Earnings / Catalyst Window2026-11-06
14-Day Relative Strength Index (RSI)PULLBACK ZONE (42)Saku Momentum Pulse & Health Rating20/100 Momentum • 25/100 Health
Want live sub-second candlesticks, 20D SMA / 50D EMA overlays, and real-time Support & Resistance alerts on $MRNA?Launch Interactive $MRNA Chart
Saku AI Bull vs. Bear Breakdown

Should You Buy $MRNA Stock Now or Wait?

$MRNA Bull CaseUPSIDE DRIVERS

Moderna's positive Phase 3 results for its personalized mRNA cancer vaccine, intismeran, in melanoma patients, along with recent FDA approvals for updated COVID-19 vaccines and an analyst upgrade to 'buy' with a $180 price target, highlight strong long-term pipeline potential and future revenue streams.

Momentum Pulse: 20/100 (STORMY)Predict Bull Target
$MRNA Bear Case & RisksRISK FACTORS

The upsized $2.6 billion convertible senior notes offering raises significant concerns about future share dilution, while the company continues to report substantial losses and negative cash flow, with the average analyst price target remaining significantly below current trading levels.

Fundamental Health: 25/100 ScoreAudit Downside Risk
Technicals, Volume & Catalysts

$MRNA Support & Resistance, Institutional Flow & Catalysts.

Key Price Zones

$MRNA Support & Resistance

Spot Price: $198.85 | 30-Day Support Floor: $195.00 (1.94% above) | 10-Day EMA: $219.16 | 20-Day SMA Pivot: $225.26 | 30-Day Resistance Ceiling: $269.00 (35.28% below) | 14-Day RSI: 42 (PULLBACK ZONE (42)) | 30-Day Trading Corridor: 37.95% span. AI Desk Note: Immediate support for MRNA is identified in the $133-$136 zone, with further support at $127.80, while immediate resistance is around the prior close of $142.77 and the $147.55 level.

Chart IndicatorsSMA • EMA • RSI
Volume & Options Activity

$MRNA Institutional & Whale Flow

Institutional activity indicates a net cautious flow as concerns over dilution from the upsized $2.6 billion convertible note offering appear to outweigh any positive sentiment, with 14.83% of the public float held short as of mid-August.

Saku Pro Deep-DiveTRACKED
Upcoming Events

$MRNA Catalyst Outlook

Key upcoming events include the full Phase 3 data presentation for the INTerpath-001 melanoma vaccine, planned FDA discussions for the cancer vaccine, results from trials in other cancer types, and an Analyst Day scheduled for November 12, 2026.

Asset & Corporate Profile

About Moderna, Inc. ($MRNA)

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more. With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.

Saku's quantitative engine continuously monitors $MRNA's 30-day mechanical support floor ($195.00), 20-day simple moving average ($225.26), and 30-day resistance ceiling ($269.00) alongside off-exchange dark pool block prints and SEC filings.

Market Cap$77.85B
5-Day Velocity-12.70%
52-Week Range$23.55 – $280.80
Avg Daily Vol12.14M shares
Inspect Full $MRNA Fundamentals in Terminal
3D Agent Sanctuary • Workstation #4🔥 Early Adopter Lock-In (First 500 Desks)🎁 Code LINKEDIN: 30 Days Pro Free

Hatch Your Own 24/7 AI Co-Pilot to Guard $MRNA.

Step inside the 3D Quant Sanctuary and claim Workstation #4 to hatch your personal AI analyst (Momentum, Dip-Buyer, or Value & Catalyst style). Your agent monitors $MRNA 24/7 with locked 1-month price targets, hard stop-loss tripwires, 3x/day shift briefings, and live Koi Bridge debates.

Unlock all 4 Autonomous Quant Agents & 24/7 Stop-Loss Guard:$29/mo$14.99/mo(or $8.33/mo annual • Early Adopter Rate + 30 Days Free w/ code LINKEDIN)
app.sakustocks.com • Live $MRNA Terminal & Agent Sanctuary
Launch Full Terminal
Saku Institutional AI Terminal analyzing $MRNA (Moderna, Inc.)
“Ask @Saku or Ronin: Would you buy $MRNA right now or wait for a pullback?”
5 Guard Slots • 50 Daily @Saku Queries
Frequently Asked Questions About $MRNA

What are the live 30-day support and resistance levels for $MRNA (Moderna, Inc.)?

Spot Price: $198.85 | 30-Day Support Floor: $195.00 (1.94% above) | 10-Day EMA: $219.16 | 20-Day SMA Pivot: $225.26 | 30-Day Resistance Ceiling: $269.00 (35.28% below) | 14-Day RSI: 42 (PULLBACK ZONE (42)) | 30-Day Trading Corridor: 37.95% span. AI Desk Note: Immediate support for MRNA is identified in the $133-$136 zone, with further support at $127.80, while immediate resistance is around the prior close of $142.77 and the $147.55 level. $MRNA currently registers a Saku Momentum Pulse score of 20/100 and a Fundamental Health score of 25/100.

Why is $MRNA (Moderna, Inc.) moving and what is the bull vs. bear thesis?

Bull Thesis: Moderna's positive Phase 3 results for its personalized mRNA cancer vaccine, intismeran, in melanoma patients, along with recent FDA approvals for updated COVID-19 vaccines and an analyst upgrade to 'buy' with a $180 price target, highlight strong long-term pipeline potential and future revenue streams. Bear Thesis: The upsized $2.6 billion convertible senior notes offering raises significant concerns about future share dilution, while the company continues to report substantial losses and negative cash flow, with the average analyst price target remaining significantly below current trading levels.

What are $MRNA's key fundamentals, 52-week range, and upcoming catalysts?

Moderna, Inc. ($MRNA) trades with a market cap of $77.85B, and a 52-week range of $23.55 to $280.80. Key upcoming events include the full Phase 3 data presentation for the INTerpath-001 melanoma vaccine, planned FDA discussions for the cancer vaccine, results from trials in other cancer types, and an Analyst Day scheduled for November 12, 2026.

Saku Tracked Assets

Explore More AI Stock & Crypto Quant Dossiers

View 14-Day Catalyst Calendar →

© 2026 Saku Financial Inc. Saku™ is a trademark of Saku Financial Inc.